Frank E. Kwarcinski

492 total citations
18 papers, 310 citations indexed

About

Frank E. Kwarcinski is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Frank E. Kwarcinski has authored 18 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Computational Theory and Mathematics. Recurrent topics in Frank E. Kwarcinski's work include Protein Kinase Regulation and GTPase Signaling (9 papers), Melanoma and MAPK Pathways (4 papers) and Computational Drug Discovery Methods (3 papers). Frank E. Kwarcinski is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (9 papers), Melanoma and MAPK Pathways (4 papers) and Computational Drug Discovery Methods (3 papers). Frank E. Kwarcinski collaborates with scholars based in United States, Germany and France. Frank E. Kwarcinski's co-authors include Matthew B. Soellner, Christel C. Fox, Michael E. Steffey, Gregory G. Tall, Sameer Phadke, Taylor K. Johnson, Alexander Vizurraga, Makaía M. Papasergi-Scott, Kristoffer Brandvold and Jeanne A. Stuckey and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Frank E. Kwarcinski

18 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank E. Kwarcinski United States 9 228 66 48 47 44 18 310
Anthony C. Bishop United States 7 255 1.1× 76 1.2× 26 0.5× 23 0.5× 54 1.2× 11 392
Samia Aci‐Sèche France 12 241 1.1× 50 0.8× 21 0.4× 88 1.9× 48 1.1× 27 361
Chan-I Chung United States 13 444 1.9× 53 0.8× 43 0.9× 20 0.4× 99 2.3× 18 516
Victoria Georgi Germany 10 169 0.7× 26 0.4× 39 0.8× 34 0.7× 22 0.5× 24 297
Neta Gurwicz Israel 6 239 1.0× 119 1.8× 21 0.4× 16 0.3× 76 1.7× 6 326
Marco Marenchino Spain 10 223 1.0× 36 0.5× 13 0.3× 27 0.6× 43 1.0× 15 317
Andrea Missio Italy 8 344 1.5× 139 2.1× 46 1.0× 38 0.8× 75 1.7× 10 499
Vanessa Buosi United States 7 323 1.4× 29 0.4× 26 0.5× 35 0.7× 69 1.6× 7 394
William M. Marsiglia United States 11 265 1.2× 23 0.3× 16 0.3× 24 0.5× 53 1.2× 16 364
Carlo Baggio United States 14 336 1.5× 235 3.6× 60 1.3× 35 0.7× 143 3.3× 28 539

Countries citing papers authored by Frank E. Kwarcinski

Since Specialization
Citations

This map shows the geographic impact of Frank E. Kwarcinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank E. Kwarcinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank E. Kwarcinski more than expected).

Fields of papers citing papers by Frank E. Kwarcinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank E. Kwarcinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank E. Kwarcinski. The network helps show where Frank E. Kwarcinski may publish in the future.

Co-authorship network of co-authors of Frank E. Kwarcinski

This figure shows the co-authorship network connecting the top 25 collaborators of Frank E. Kwarcinski. A scholar is included among the top collaborators of Frank E. Kwarcinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank E. Kwarcinski. Frank E. Kwarcinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Horibata, Yasuhiro, Frank E. Kwarcinski, Ashleigh M. Raczkowski, et al.. (2025). Structural basis for catalysis and selectivity of phospholipid synthesis by eukaryotic choline-phosphotransferase. Nature Communications. 16(1). 111–111. 2 indexed citations
2.
Vizurraga, Alexander, et al.. (2023). GPR114/ADGRG5 is activated by its tethered peptide agonist because it is a cleaved adhesion GPCR. Journal of Biological Chemistry. 299(10). 105223–105223. 8 indexed citations
3.
Ong, Han Wee, et al.. (2023). Characterization of 2,4-Dianilinopyrimidines Against Five P. falciparum Kinases PfARK1, PfARK3, PfNEK3, PfPK9, and PfPKB. ACS Medicinal Chemistry Letters. 14(12). 1774–1784. 3 indexed citations
4.
Tiek, Deanna, Carrow I. Wells, Martin Schröder, et al.. (2023). SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4. PubMed. 3. 100045–100045. 1 indexed citations
5.
Papasergi-Scott, Makaía M., et al.. (2023). Structures of Ric-8B in complex with Gα protein folding clients reveal isoform specificity mechanisms. Structure. 31(5). 553–564.e7. 8 indexed citations
6.
Barros-Álvarez, Ximena, Robert M. Nwokonko, Alexander Vizurraga, et al.. (2022). The tethered peptide activation mechanism of adhesion GPCRs. Nature. 604(7907). 757–762. 85 indexed citations
7.
Ong, Han Wee, Frank E. Kwarcinski, Tammy M. Havener, et al.. (2022). Discovery of potent Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors with a type II inhibitor pharmacophore. European Journal of Medicinal Chemistry. 249. 115043–115043. 10 indexed citations
8.
Asquith, Christopher R. M., Michael P. East, Tuomo Laitinen, et al.. (2022). Identification of 4‐Anilinoquin(az)oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype**. ChemMedChem. 17(12). e202200161–e202200161. 3 indexed citations
9.
Kwarcinski, Frank E., Tammy M. Havener, Han Wee Ong, et al.. (2022). Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial Pf GSK3/ Pf PK6 with Activity against Blood Stage Parasites In Vitro. Journal of Medicinal Chemistry. 65(19). 13172–13197. 7 indexed citations
10.
Papasergi-Scott, Makaía M., et al.. (2022). Structures of Ric-8B in Complex With Gα Protein Folding Clients Reveal Isoform Specificity Mechanisms. SSRN Electronic Journal. 1 indexed citations
11.
Chaikuad, A., Carrow I. Wells, Safal Shrestha, et al.. (2020). A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation. Journal of Medicinal Chemistry. 63(23). 14626–14646. 17 indexed citations
12.
Agius, Michael P., et al.. (2019). Selective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src Kinase. ACS Chemical Biology. 14(7). 1556–1563. 12 indexed citations
13.
Kwarcinski, Frank E., Kristoffer Brandvold, Sameer Phadke, et al.. (2016). Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity. ACS Chemical Biology. 11(5). 1296–1304. 58 indexed citations
14.
Kwarcinski, Frank E., Michael E. Steffey, Christel C. Fox, & Matthew B. Soellner. (2015). Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration. ACS Medicinal Chemistry Letters. 6(8). 898–901. 14 indexed citations
15.
Breen, Meghan E., et al.. (2014). Substrate Activity Screening with Kinases: Discovery of Small‐Molecule Substrate‐Competitive c‐Src Inhibitors. Angewandte Chemie International Edition. 53(27). 7010–7013. 19 indexed citations
16.
Breen, Meghan E., et al.. (2014). Substrate Activity Screening with Kinases: Discovery of Small‐Molecule Substrate‐Competitive c‐Src Inhibitors. Angewandte Chemie. 126(27). 7130–7133. 4 indexed citations
17.
Kwarcinski, Frank E., Christel C. Fox, Michael E. Steffey, & Matthew B. Soellner. (2012). Irreversible Inhibitors of c-Src Kinase That Target a Nonconserved Cysteine. ACS Chemical Biology. 7(11). 1910–1917. 38 indexed citations
18.
Dye, James L., Partha Nandi, James E. Jackson, et al.. (2011). Nano-Structures and Interactions of Alkali Metals within Silica Gel. Chemistry of Materials. 23(9). 2388–2397. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026